You are here

Company Monitoring Page for biotech

latest headlines for company on cafepharma

Top Biotechs Set to Win in the War on Cancer

Yahoo/Wall St 24-7

Thu, 10/3/13 - 11:57 am

Tags:

biotech, Biomarin, Immunogen, Ariad Pharmaceuticals, Amgen, Celgene, Gilead Sciences

Investing Smart: Biotechs, Effective Therapies And Shareholder-Friendly CEOs

Seeking Alpha

Wed, 10/2/13 - 10:15 am

Tags:

biotech, Jazz Pharmaceuticals, Questcor, Spectrum Pharmaceuticals, NeoStem, NewLink Genetics, Dendreon, Galena Biopharma, Roche, ImmunoCellular Therapeutics

3 Signs We Could Be Entering a Biotech Bubble

Motley Fool

Sat, 09/28/13 - 01:09 pm

Tags:

biotech, Perrigo, Bristol-Myers Squibb, Elan, Clovis Oncology, IPOs, Stemline, Amgen, Biogen Idec, ONYX Pharmaceuticals

FierceBiotech's 2013 Fierce 15

Fierce Biotech

Wed, 09/25/13 - 01:04 pm

Tags:

biotech, AnaptysBio, Acetylon Pharmaceuticals, CytomX, Immunocore, FibroGen, Jounce Therapeutics, Kala Pharmaceuticals, Macrogenics, Moderna Therapeutics, Presage Biosciences, Nimbus Discovery, Scioderm, Ultragenyx, uniQure, Visterra

5 Biotech Stocks Under $10 on the Move

TheStreet.com

Fri, 09/20/13 - 12:34 pm

Tags:

biotech, Organovo, Supernus Pharmaceuticals, ARCA biopharma, Cerus, Transition Therapeutics

Google's biotech plan: Partner with legendary CEO, tackle aging, think outside the cancer box

Fierce Biotech

Thu, 09/19/13 - 08:19 am

Tags:

Google, biotech, aging, Larry Page, Art Levinson, Calico

[video]Biotech IPOs With Big Partners

TheStreet.com

Thu, 09/19/13 - 03:13 am

Tags:

biotech, IPOs, Celgene, Amgen, Bind Therapeutics, Acceleron, Fate Therapeutics

Biotechs keep the cash pumping (for now) with more IPOs and ATMs

Fierce Biotech

Tue, 09/17/13 - 10:01 am

Tags:

IPOs, Fate Therapeutics, biotech, ATMs

Have These 4 Biotechs Peaked?

Motley Fool

Mon, 09/16/13 - 11:04 am

Tags:

biotech, Alexion, Pharmacyclics, Aegerion, Raptor Pharmaceuticals

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

Yahoo/Wall St 24-7

Mon, 09/16/13 - 10:09 am

Tags:

biotech, Th2 immune pathway, MS, multiple sclerosis, Biogen Idec, Regeneron, Sanofi, GSK

Biotech Indicators Rose Last Year, But So Did Losses: Survey

Pharmalot

Thu, 09/12/13 - 10:10 am

Tags:

Are Biotech M&A Premiums Already Built In? Valuations Do Matter

Seeking Alpha

Tue, 09/3/13 - 04:19 pm

Tags:

biotech, M&A, ONYX Pharmaceuticals, Alexion, Biomarin, Incyte, Medivation, Pharmacyclics, Regeneron, Seattle Genetics

ImClone’s Waksal Back in Biotech With Plans for Spinouts

Bloomberg

Tue, 09/3/13 - 10:45 am

Tags:

ImClone, Sam Waksal, biotech, Kadmon

Is the Biotech Bubble About to Burst?

Motley Fool

Wed, 08/28/13 - 11:31 am

Tags:

biotech, Cytokinetics, Amgen, Celgene, Astex

Big Pharma Shrinks Headcount, But Biotech Hiring Compensates

Pharmalot

Mon, 08/19/13 - 10:19 am

Tags:

biotech, hirings, layoffs

The hottest disease field for biotech startups and M&A might surprise you

Fierce Biotech

Fri, 08/16/13 - 09:25 am

Tags:

biotech, start-ups, M&A, CNS

Can Biotech Earnings Hold Up?

Forbes

Tue, 07/30/13 - 01:31 pm

Tags:

biotech, earnings

The biotech IPO scene turns red hot

Fierce Biotech

Thu, 07/11/13 - 11:24 am

Tags:

A View Through An Open Window For Biotech IPOs

Forbes

Tue, 07/9/13 - 12:29 pm

Tags:

The Best- And Worst-Performing Biotech Stocks, June 28 to July 5

Forbes

Mon, 07/8/13 - 11:02 am

Pages

last 30 twitter posts